Standardizing Reporting Practices for Isokinetic Testing: a Delphi Study (NCT06733116) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Standardizing Reporting Practices for Isokinetic Testing: a Delphi Study
30 participantsStarted 2025-01-01
Plain-language summary
Isokinetic testing plays a crucial role in research and clinical practice, particularly for evaluating muscle strength, functional performance, and imbalances between muscle groups in fields such as rehabilitation, sports medicine, and orthopedics. Despite its widespread use, there is no international consensus on how to standardize protocols or report results, leading to significant variability in methodologies, measurement parameters, and data presentation.
This Delphi method study aims to develop a consensus framework for standardizing the reporting of isokinetic testing data, ensuring consistency and comparability in research and clinical practices.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Demonstrated knowledge or experience in isokinetic testing, such as research, clinical practice, or equipment design.
* Clinicians, researchers, educators, or professionals with relevant expertise in rehabilitation, sports medicine, biomechanics, or related fields.
* At least 5 peer-reviewed publication (first author) or equivalent contribution in the field of isokinetic testing or related domains.
* Minimum of 5 years of professional experience in a relevant field.
* Agreement to participate in all Delphi rounds and provide informed consent.
* Ability to communicate and provide responses in the language used for the study (English).
Exclusion Criteria:
* Professionals with conflicts of interest that could bias their contributions, such as direct financial ties to specific isokinetic testing equipment manufacturers.
* Inability or unwillingness to commit to the iterative Delphi process, including providing timely responses to questionnaires.
* Accidental inclusion of an expert already represented in another capacity within the study (e.g., as a member of the organizing committee).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Consensus on Key Elements for Standardized Reporting of Isokinetic Testing
Timeframe: At the completion of the final Delphi round (approximately 6 months).